Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer

PURPOSE: Trastuzumab (TZM) improves survival and the risk of recurrence among patients with early-stage HER2+ breast cancer (BC). TZM treatment can be given intravenously (IV-TZM) or subcutaneously (SC-TZM). Although both methods have similar efficacy and safety, they differ in dosage and administra...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Rojas, Luis, Muñiz, Sabrina, Medina, Lidia, Peña, Jose, Acevedo, Francisco, Pinto, Mauricio P., Sanchez, Cesar
格式: Artigo
語言:Inglês
出版: Public Library of Science 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001963/
https://ncbi.nlm.nih.gov/pubmed/32023267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0227961
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍